Today

Agents

Chat

Arena

Discover

More

App

NervGen Pharma publishes restated annual financial report - NGEN News | Rallies

NervGen Pharma publishes restated annual financial report

NGEN•2026-10-16

NervGen Pharma published restated consolidated financial statements for the fiscal years ended December 31, 2025 and 2024.

1. Restated statements published

NervGen Pharma published restated consolidated financial statements for the fiscal years ended December 31, 2025 and 2024.

Related News

Foreign US Treasury holdings rise in August, but China cuts to 2008 low

TLT•2026-10-16

Weatherford International files initial beneficial ownership statement for SVP and Chief Accounting Officer Maximiliano Kricorian

WFRD•2026-10-16

Enliven Therapeutics files initial beneficial ownership statement for director Kristine M. Ball

Sources

S

NervGen Pharma publishes restated annual financial report

Sec

ELVN•2026-10-16

Morningstar DBRS confirms Republic of Italy at A (Low), stable trend

TLT•2026-10-16

Waterstone Financial director Derek Tyus resigns, effective Oct. 20

WSBF•2026-10-16